Conclusion GLP-1 receptor agonists represent a significant advancement in managing pediatric diabetes and obesity, providing options that directly address insulin resistance, promote weight loss and reduce risks from related comorbidities
For a detailed discussion of the history of neurostimulators policy, we refer readers to the CY 2015, CY 2020, CY 2021, CY 2023, CY 2024, and CY 2025 OPPS/ASC final rules with comment period (79 FR 66807 through 66808
Manage Stress For many people, stress leads to emotional or mindless eating reaching for comfort foods, snacking out of habit, or skipping meals and then overeating later
Over time, the brain unlearns the pull toward alcohol
Since the HPT axis plays a fundamental role in metabolic pathways involving lipids and carbohydrates, the existence of a link between TH dysfunction and liver diseases has been explored over the years